Targeting HIF-2α as therapy for advanced cancers. - Murugesan, Thanabal; Rajajeyabalachandran, Gurukumari; Kumar, Swetha; Nagaraju, Shruthi; Jegatheesan, Sooriya Kumar (Drug Discovery Today, 2018)